Table 2.
Presence of TTH at follow-up | ||||
---|---|---|---|---|
Yes | No | Total, n (%) | p-value | |
Muscle-related TMD pain, n (%) | 0.05* | |||
Yes | 24 (27.3) | 66 (17.6) | 90 (19.4) | |
No | 64 (72.7) | 310 (82.4) | 374 (80.6) | |
Total | 88 (100) | 376 (100) | 464 (100) | |
Joint-related TMD pain, n (%) | 0.48* | |||
Yes | 4 (4.5) | 28 (7.4) | 32 (6.9) | |
No | 84 (95.5) | 348 (92.6) | 432 (93.1) | |
Total | 88 (100) | 376 (100) | 464 (100) | |
Gender, n (%) | 0.01* | |||
Males | 14 (15.9) | 111 (29.5) | 125 (26.9) | |
Females | 74 (84.1) | 265 (70.5) | 339 (73.1) | |
Total | 88 (100) | 376 (100) | 464 (100) | |
Age, mean (SD) | 44.3 (9.2) | 46.0 (10.8) | 0.31† | |
Education level, n (%) | < 0.01* | |||
Low | 9 (10.2) | 92 (24.5) | 101 (21.8) | |
Medium | 23 (26.1) | 132 (35.1) | 155 (33.4) | |
High | 56 (63.6) | 152 (40.4) | 208 (44.8) | |
Total | 88 (100) | 376 (100) | 464 (100) | |
BMI, mean (SD) | 25.5 (4.8) | 26.1 (4.1) | 0.08† | |
Use of anti-inflammatory drugs, n (%) | 0.47* | |||
Yes | 51 (60.0) | 200 (54.9) | 251 (55.9) | |
No | 34 (40.0) | 164 (45.1) | 198 (44.1) | |
Total | 85 (100) | 364 (100) | 449 (100) |
*p-value calculated through chi-square test
†p-value calculated through Mann–Whitney U test